Peer Review Process

When submitting a manuscript to Current Pharma Science Research, the authors should affirm that the work has been exclusively submitted to the journal, not published elsewhere, simultaneously submitted, or already accepted elsewhere. The journal requires one authorized corresponding author to handle all matters related to the manuscript. Upon receipt, all manuscripts were acknowledged and underwent an initial review by the editors for suitability. Those lacking originality, significant scientific flaws, or substantial messages are rejected before formal peer review. Manuscripts that are unlikely to interest the journal's readers may also be rejected at this stage. Suitable manuscripts were formally reviewed by two or more expert reviewers. The authors are encouraged to suggest potential reviewers, although the editor retains their discretion in the selection process. The journal employs a double-blind review to ensure anonymity between reviewers and authors. The final decision was made by an assigned editorial team member based on the reviewer’s comments. The authors received reviewer comments and may be asked for a point-by-point response, submitting revised manuscripts as needed. This iterative process continues until both the reviewers and editors are satisfied. Accepted manuscripts have undergone copy-editing for grammar, punctuation, style, and format. Page proofs are sent to the corresponding author, who is expected to promptly return the corrected proofs. The corrections received after a specified period may not have been incorporated. For swift dissemination, the journal publishes accepted articles online as 'Ahead of Print' immediately upon acceptance, completing the entire process from submission to online publication.